Myla Lai-Goldman
InvestorVenture Partner at Hatteras Venture Partners · Board director at GeneCentric
Burlington, Vermont
Writes $100K – $5M checks · typically $1.5M
About
Myla Lai-Goldman is Chair and Co-Founder of GeneCentric Therapeutics, Inc. and serves as a Board Member at Mercy BioAnalytics, Inc. She spent over 18 years at LabCorp, including 10 years as Executive Vice President, Chief Medical Officer and Chief Scientific Officer, where she oversaw three genomic laboratories and led the introduction of more than 400 clinical assays. She holds a BS from the University of Pennsylvania and an MD from Columbia University College of Physicians and Surgeons, and is board-certified in anatomic and clinical pathology.
Contact· self-published, not guessed
Board director at GeneCentric
Intro paths
→
In turn, Myla can intro founders to GeneCentric's investors below.
GeneCentric's investors · 2
Experience
- Mercy BioAnalytics, Inc.Board Membercurrent2023 — present
- NovoPathBoard Membercurrent2022 — present
- GeneCentric Therapeutics, Inc.Co-Founder and Chaircurrent2021 — present
- GeneCentric Therapeutics, Inc.Executive Chair2019 — 2021Research Triangle Park, NC
- GeneCentric Therapeutics, Inc.Chief Executive Officer2011 — 2018280 S. Mangum Street Suite 350 Durham, NC 27701
- West Pharmaceutical ServicesBoard Membercurrent2014 — present
- Hatteras Venture PartnersVenture Partnercurrent2011 — present280 S Mangum St, Suite 350 Durham, NC 27701
- Personalized Science, LLCManaging Partnercurrent2009 — presentS Burlington, Vermont
- QuanterixBoard Member2025 — 2026
- Hitachi High-Tech America, Inc.Scientific Advisory Board Member2023 — 2026
- Akoya Biosciences, Inc.Board Member2021 — 2025
- LabCorpExecutive VP, CMO & CSO1998 — 2008128 East Maple Avenue, Burlington, NC 27215
- LabCorpPathologist, VP, SVP1990 — 1998
Skills & more
Strategy7Diagnostics2Hardware Diagnostics31Infectious Diseases13Biotechnology46Oncology34Personalized Medicine8Genomics8Lifesciences30Cancer7Commercialization38Immunology11
+12 more
Molecular BiologyClinical DevelopmentDrug DevelopmentTechnology TransferDrug DiscoveryPharmaceutical IndustryBiopharmaceuticalsHealthcareGeneticsBiochemistryMedical DevicesClinical TrialsFrom Myla's professional profile.
Investments
Board seats
Per SEC Form D filings.
Colleagues at Hatteras Venture Partners
Alston Gardner
Special Advisor at Hatteras Venture Partners
Ben Scruggs
Partner at Hatteras Venture Partners
Ben Scruggs, PhD
Partner at Hatteras Venture Partners
Christy Shaffer
General Partner at Hatteras Venture Partners
Christy Shaffer, PhD
General Partner at Hatteras Venture Partners
Clay Thorp
General Partner at Hatteras Venture Partners
Declan Devens
Operations Analyst at Hatteras Venture Partners
Douglas Reed
General Partner at Hatteras Venture Partners
Frequently asked questions
- Who is Myla Lai-Goldman?
- Myla Lai-Goldman is Chair and Co-Founder of GeneCentric Therapeutics, Inc. and serves as a Board Member at Mercy BioAnalytics, Inc. She spent over 18 years at LabCorp, including 10 years as Executive Vice President, Chief Medical Officer and Chief Scientific Officer, where she oversaw three genomic laboratories and led the introduction of more than 400 clinical assays. She holds a BS from the University of Pennsylvania and an MD from Columbia University College of Physicians and Surgeons, and is board-certified in anatomic and clinical pathology.
- Where does Myla Lai-Goldman work?
- Myla Lai-Goldman is Venture Partner at Hatteras Venture Partners and Board director at GeneCentric.
- What check size does Myla Lai-Goldman write?
- Myla Lai-Goldman typically writes checks of $100K – $5M.
- What boards does Myla Lai-Goldman sit on?
- Myla Lai-Goldman holds tracked board seats at GeneCentric.
- Where did Myla Lai-Goldman go to school?
- Myla Lai-Goldman studied at Columbia University Vagelos College of Physicians and Surgeons (Doctor of Medicine (MD)); University of Pennsylvania (Bachelor of Arts (B.A.), Biology).
Founder mafias
University of Pennsylvania mafia201
Also came through, then founded or led a company.
Kunal BahlSystems EngineeringFounded SnapdealScott Wolf, MDBAFounded Cardiac Dimensions +3Ben LererBSFounded Thrillist +1Eric HeilBSEFounded Ladderbio +1Trevor PriceB.A.Founded Quilted Health +1Lyle BerkowitzBSEFounded Apollo Health +1
%20(1).webp)
+ 194 more
Columbia University Vagelos College of Physicians and Surgeons mafia5
Also came through, then founded or led a company.
Hatteras Venture Partners mafia4
Also came through, then founded or led a company.
Quanterix mafia2
Also came through, then founded or led a company.
Same school
Also attended Columbia University Vagelos College of Physicians and Surgeons20
Tristan HuntPartner at Averin CapitalDeborah PalestrantPartner, Executive Chair, 4:59 Initiative at 5AM VenturesShreeram AradhyeInvestor at Novartis Venture FundJoseph MayerPartner at HLM Investment PartnersJoan LaRovereOperating Partner at iSelect FundCurt LaBelleVenture Partner at Adjuvant Capital
+ 14 more
Also attended University of Pennsylvania1,026
Brian ActonCo-founder of WhatsApp; co-founder of Signal FoundationKunal BahlCo-founder of Snapdeal; co-founder of Titan CapitalDasha MaggioPartner at Felicis Ventures, writer on venture capital and founder psychologyNancy WangInvestor at Felicis VenturesLeah von SiemensPartner at Manta Ray VenturesEghosa OmoiguiFounder and Managing General Partner at EchoVC Partners
+ 1,020 more
